ALFA Finder| Revenue growth | 26.6% YoY in Q4; 19.5% for full year FY26. |
|---|---|
| Margins | EBITDA margins improved 379 bps YoY to 43.5% in Q4. |
| Demand visibility | Strong momentum in wellness segment and new geographies like Kolkata. |
| Management confidence | High; confident in doubling Pune revenue and maintaining 40%+ margins. |
Growth
FY26 revenue grew 19.5% YoY to ₹814cr; Q4 PAT grew 37.5% YoY to ₹47.9cr with 43.5% EBITDA margin.
Outlook
FY27 capex of ₹140-150cr for 4-5 hubs and 10-12 spokes; targeting 40%+ EBITDA margins.
Risks
Competition from hospital-based labs and online aggregators; high traffic in new markets like Bangalore affecting logistics.
Earnings Call filed with BSE, NSE: VIJAYA. Summary written with AI assistance from the document.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,422.70
- Market cap
- ₹14,653 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 71.9×Sector 54.5×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Earnings Call Transcript: Key Takeaways
Vijaya Diagnostic delivered strong Q2 growth, leveraging operating leverage and CGHS tariff revisions to expand margins significantly despite aggressive network expansion.
- Call
- Guides 20% growth
Vijaya Diagnostic Centre Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,554 Mn (+26.7%), EBITDA ₹1,128 Mn (44.1% margin), PAT ₹595 Mn (23.3%). Strategy: hub-and-spoke densification, Bengaluru/Hyderabad hubs, Guwahati entry.
Vijaya Diagnostic Centre Results Update
Vijaya Diagnostic's Q2 FY27 press release reports revenue up 26.7% and PAT up 37.4% year-on-year. It also notes an agreement to acquire Arya Wellness Centre in Guwahati.
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre appointed Rahul Jain as Company Secretary and Compliance Officer, designated KMP, effective November 03, 2026. The appointment follows the Nomination and Remuneration Committee's recommendation.
Vijaya Diagnostic Centre Q2 FY27 Results: Net Profit ₹59.5 Cr, Up 37.4% YoY
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹255.4 Cr (+26.7% YoY) and net profit of ₹59.5 Cr (+37.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹59.5 Cr · +37.4% YoY
Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.